Anne Cristine Guevarra

ORCID: 0000-0003-1817-7130
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dementia and Cognitive Impairment Research
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Acute Ischemic Stroke Management
  • Stroke Rehabilitation and Recovery
  • Alzheimer's disease research and treatments
  • Neurological Disease Mechanisms and Treatments
  • Cerebrovascular and Carotid Artery Diseases
  • Trauma and Emergency Care Studies
  • Bipolar Disorder and Treatment
  • Neurological diseases and metabolism
  • Immune Cell Function and Interaction
  • Amyotrophic Lateral Sclerosis Research
  • Frailty in Older Adults
  • Retinopathy of Prematurity Studies
  • Cardiac Arrest and Resuscitation
  • Cancer Treatment and Pharmacology
  • Cardiovascular Health and Disease Prevention
  • Traumatic Brain Injury Research
  • Neurosurgical Procedures and Complications
  • Glioma Diagnosis and Treatment
  • Respiratory viral infections research
  • Viral Infections and Vectors
  • Immunotherapy and Immune Responses
  • Neuroblastoma Research and Treatments
  • Atrial Fibrillation Management and Outcomes

Cedars-Sinai Medical Center
2025

National Neuroscience Institute
2017-2024

St. Luke's Medical Center
2020

Sansum Medical Clinic
2004

Jonathan G. Best Gareth Ambler Duncan Wilson Keon‐Joo Lee Jae‐Sung Lim and 95 more Masayuki Shiozawa Masatoshi Koga Linxin Li Caroline Lovelock Hugues Chabriat Michael G. Hennerici Yuen Kwun Wong Henry Ma Luís Prats‐Sánchez Alejandro Martínez‐Domeño Shigeru Inamura Kazuhisa Yoshifuji Ethem Murat Arsava Solveig Horstmann Jan Purrucker Bonnie Yin Ka Lam Adrian Wong Young Dae Kim Tae‐Jin Song Robin Lemmens Sebastian Eppinger Thomas Gattringer Ender Uysal Zeynep Tanrıverdi Natan M. Bornstein Einor Ben Assayag Hen Hallevi Jeremy Molad Masashi Nishihara Jun Tanaka Shelagh B. Coutts Alexandros A. Polymeris Benjamin Wagner David Seiffge Philippe Lyrer Ale Algra L. Jaap Kappelle Rustam Al‐Shahi Salman Hans Rolf Jäger Gregory Y.H. Lip Urs Fischer Marwan El‐Koussy Jean‐Louis Mas Laurence Legrand Christopher C. Karayiannis Thanh G. Phan Sarah Gunkel Nicolas Christ Jill Abrigo Thomas Leung Chiu‐Wing Winnie Chu Francesca M. Chappell Stephen Makin Derek Hayden David Williams Werner H. Mess Paul J. Nederkoorn Carmen Barbato Simone Browning Beom Joon Kim Anil M. Tuladhar Noortje A.M. Maaijwee Anne Cristine Guevarra Chathuri Yatawara Anne‐Marie Mendyk Christine Delmaire Sebastian Köhler Robert van Oostenbrugge Ying Zhou Chao Xu Saima Hilal Bibek Gyanwali Christopher Chen Min Lou Julie Staals Régis Bordet Nagaendran Kandiah Frank‐Erik de Leeuw Robert Simister Jeroen Hendrikse John Ly Joanna M. Wardlaw Yannie Soo Felix Fluri Velandai Srikanth D. Calvet Simon Jung Vincent I.H. Kwa Stefan T. Engelter Nils Peters Eric E. Smith Hideo Hara Yusuke Yakushiji Dilek Neci̇oğlu Örken Franz Fazekas

10.1016/s1474-4422(21)00024-7 article EN publisher-specific-oa The Lancet Neurology 2021-03-18

Background:Hypertension and white matter hyperintensities (WMH) are mutually associated risk factors for cognitive impairment. However, age may modify the associations between hypertension WMH, their links to Objective:We evaluated interaction hyper tension on age-stratified of WMH with cognition. Methods:Key measures include systolic blood pressure (SBP), (modified Fazekas visual ratings cranial MRI), Montreal Cognitive Assessment (MoCA). Participants (N = 488) prodromal mild dementia were...

10.3233/jad-191260 article EN Journal of Alzheimer s Disease 2020-05-12
Simon Fandler‐Höfler Sebastian Eppinger Gareth Ambler Philip S. Nash Markus Kneihsl and 95 more Keon-Joo Lee Jae‐Sung Lim Masayuki Shiozawa Masatoshi Koga Linxin Li Caroline Lovelock Hugues Chabriat Michael G. Hennerici Yuen Kwun Wong Henry Ma Luís Prats‐Sánchez Alejandro Martínez‐Domeño Shigeru Inamura Kazuhisa Yoshifuji Ethem Murat Arsava Solveig Horstmann Jan Purrucker Bonnie Yin Ka Lam Adrian Wong Young Dae Kim Tae‐Jin Song Robin Lemmens Ender Uysal Zeynep Tanrıverdi Natan M. Bornstein Einor Ben Assayag Hen Hallevi Jeremy Molad Masashi Nishihara Jun Tanaka Shelagh B. Coutts Alexandros A. Polymeris Benjamin Wagner David Seiffge Philippe Lyrer L. Jaap Kappelle Rustam Al‐Shahi Salman María Valdés Hernández Hans Rolf Jäger G. Y. H. Lip Urs Fischer Marwan El‐Koussy Jean‐Louis Mas Laurence Legrand Christopher C. Karayiannis Thanh G. Phan Sarah Gunkel Nicolas Christ Jill Abrigo Chiu‐Wing Winnie Chu Thomas W. T. Leung Francesca M. Chappell Stephen Makin Derek Hayden David Williams Werner H. Mess M. Eline Kooi Carmen Barbato Simone Browning Anil M. Tuladhar Noortje A.M. Maaijwee Anne Cristine Guevarra Anne-Marie Mendyk Christine Delmaire Sebastian Köhler Robert van Oostenbrugge Ying Zhou Chao Xu Saima Hilal Caroline Robert Christopher Chen Min Lou Julie Staals Régis Bordet Nagaendran Kandiah Frank-Erik de Leeuw Robert Simister Daniel Bos John Ly Joanna M. Wardlaw Yannie Soo Felix Fluri Velandai Srikanth David Calvet Simon Jung Vincent I.H. Kwa Stefan T. Engelter Nils Peters Eric E. Smith Hideo Hara Yusuke Yakushiji Dilek Neci̇oğlu Örken Vincent Thijs Ji Hoe Heo Vincent Mok

Importance Cerebral small vessel disease (SVD) is associated with various cerebrovascular outcomes, but data on sex differences in SVD are scarce. Objective To investigate whether the frequency, severity, and distribution of cerebral microbleeds (CMB), other markers magnetic resonance imaging (MRI), outcomes differ by sex. Design, Setting, Participants This cohort study used pooled individual patient from Microbleeds International Collaborative Network, including patients 38 prospective...

10.1001/jamanetworkopen.2024.39571 article EN cc-by-nc-nd JAMA Network Open 2024-10-15

With emerging amyloid therapies, documentation of the patient's status to confirm etiology a clinical diagnosis is warranted prior instituting amyloid-based therapy. The Multimer Detection System-Oligomeric Amyloid-β (MDS-OAβ) noninvasive blood-based biomarker utilized measure Aβ oligomerization tendency. We determined difference in MDS-OAβ ratio across groups: (a) no cognitive impairment or subjective (NCI/SCI), (b) Alzheimer's disease (AD), (c) non-AD, and (d) mixed disease-Vascular...

10.1155/2022/9960832 article EN cc-by International Journal of Alzheimer s Disease 2022-05-02

Small vessel disease (SVD) and Alzheimer's (AD) frequently coexist; however, it remains unclear how they collectively affect cognition. We investigated associations between SVD AD biomarkers, namely amyloid, tau, neurodegeneration (ATN) in young onset dementia (YOD) explored ATN interact to 80 YOD individuals were recruited from a memory clinic. burden (SVD+) was operationalized as score >1 on the Staals scale measured using cerebrospinal fluid (CSF). SVD+ associated with lower CSF Aβ1-42 (B...

10.3233/jad-200311 article EN Journal of Alzheimer s Disease 2020-08-26

Background: Chronic cerebrovascular pathology accelerates the incidence of poststroke dementia (PSD). Whether risk PSD varies according to different types chronic remains unclear. Objectives: We investigated whether is associated with a unique pattern interactions between pathologies and acute stroke lesions. Materials Method: In this case-control study mild patients (n=185), cases included who developed at 6-month follow-up, controls remained nondemented 6 months, matched on prestroke...

10.1097/wad.0000000000000384 article EN Alzheimer Disease & Associated Disorders 2020-05-29

<b><i>Background:</i></b> Compared to Western populations, familial frontotemporal lobar degeneration (FTLD) is rare among Asians. Progranulin (GRN) gene mutation, which a major cause of FTLD, likewise rare. We present family with FTLD from the Philippines an autosomal dominant pattern inheritance and GRN mutation briefly review reports mutations in Asia. <b><i>Case Presentation:</i></b> The proband 66 years old progressive nonfluent aphasia...

10.1159/000510106 article EN Dementia and Geriatric Cognitive Disorders 2020-01-01

Cognitive rehabilitation programs for dementia are becoming more essential to maintain cognitive and functional performance by engaging stimulating the patients in addition medication. Not everyone will benefit from however due differences activity preference or background. The different gender, education level example may affect how readily accept engage with programs. In this study, we would like investigate long term outcomes as well interaction effect of gender levels a multi-domain...

10.1016/j.jalz.2017.06.675 article EN Alzheimer s & Dementia 2017-07-01

The presence of small vessel disease (SVD) is associated with cognitive impairment. However, among the many components SVD, contribution CMBs to impairment remain elusive. Our aim was determine if cerebral microbleeds (CMBs) contribute global and specific domains in addition that contributed by other measures burden an Asian cohort. Subjects participating a multimodal imaging study having diagnosis mild (MCI), Alzheimer's (AD) or healthy control (HC) were recruited. CMB quantified on SWI...

10.1016/j.jalz.2017.06.2365 article EN Alzheimer s & Dementia 2017-07-01

Non-pharmacological treatment has been shown to be beneficial in the maintenance of cognitive function. However, usefulness and acceptance such a programme for Asian patients not adequately studied. The OWOW! Cognitive stimulation was conceived by adapting holistic approach encompassing physical, social aspects wellbeing person with dementia. Programme structured as an eight week comprising three hour long, once weekly sessions. Each session included following components: physical exercise,...

10.1016/j.jalz.2017.06.2190 article EN Alzheimer s & Dementia 2017-07-01

Hypertensive vasculopathy and cerebral amyloid angiopathy are the two main etiologies of microbleeds (CMBs). Determining underlying cause will open doors to preventive curative strategies in future. Subjects from multimodal imaging study clinic cohort with diagnoses SCI, MCI, AD, VaD were recruited. CMBs quantified on SWI GRE images using MARS. Other markers small vessel disease assessed SVD score evaluation FLAIR T2W images. All MRI quantifications performed by a single neurologist blinded...

10.1016/j.jalz.2017.06.1059 article EN Alzheimer s & Dementia 2017-07-01

Hypertensive vasculopathy and cerebral amyloid angiopathy are the two main etiologies of microbleeds (CMBs). Determining underlying cause will open doors to preventive curative strategies in future. Subjects from multimodal imaging study clinic cohort with diagnoses SCI, MCI, AD, VaD were recruited. CMBs quantified on SWI GRE images using MARS. Other markers small vessel disease assessed SVD score evaluation FLAIR T2W images. All MRI quantifications performed by a single neurologist blinded...

10.1016/j.jalz.2017.06.2366 article EN Alzheimer s & Dementia 2017-07-01

The presence of small vessel disease (SVD) is associated with cognitive impairment. However, among the many components SVD, contribution CMBs to impairment remain elusive. Our aim was determine if cerebral microbleeds (CMBs) contribute global and specific domains in addition that contributed by other measures burden an Asian cohort. Subjects participating a multimodal imaging study having diagnosis mild (MCI), Alzheimer's (AD) or healthy control (HC) were recruited. CMB quantified on SWI...

10.1016/j.jalz.2017.06.449 article EN Alzheimer s & Dementia 2017-07-01

Abstract Background: Cerebrovascular disease (CVD) and Alzheimer’s (AD) frequently coexist however the mechanism by which they collectively affect cognition remains unclear, particularly in young onset dementia (YOD). We investigated associations between CVD AD biomarkers, namely amyloid, tau neurodegeneration (ATN) YOD, explored how ATN interact to cognition. Methods: 80 YOD individuals with mild dementia, mean age 57.73 (SD = 6.01) years were recruited from a memory clinic. MRI visual...

10.21203/rs.2.19011/v1 preprint EN cc-by Research Square (Research Square) 2019-12-16

Abstract Background Clinicians use neuropsychological assessment to screen individuals for cognitive impairment since it more convenient and can detect impaired parts of cognition provide early treatment. This study is aimed differentiate the performance on Alzheimer’s Disease Assessment Scale – Cognition (ADAS‐Cog) among older adults with normal MCI. Method The sample composed 302 participants aged ≥60 years old who met score 25 in Mini‐mental status examination (MMSE). Psychologists would...

10.1002/alz.044303 article EN Alzheimer s & Dementia 2020-12-01

Abstract Background The Asian population has been found to be at a higher risk of developing dementia compared other races due the high prevalence vascular factors. Utilization different modalities that manage these factors is focus this study in order prevent progression among senior citizens with mild cognitive impairment. Method Community‐based participants MCI were recruited join FINOMAIN Study. They divided into control and intervention groups, which INDAK (dance therapy) shall given....

10.1002/alz.042814 article EN Alzheimer s & Dementia 2020-12-01

Abstract Background Cognitive impairment in older adults is multifactorial and chronic hence, a complex intervention that can be integrated community programs major consideration for it to impact society. Designing challenging intensified with lack of research resources support its development. In this paper, we aim delve on experiences Filipino investigators designing overcoming challenges interventions elderly mild cognitive (MCI). Methods As part study process evaluation, gathered...

10.1002/alz.046653 article EN Alzheimer s & Dementia 2020-12-01
Coming Soon ...